SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.
Clinical trial NCT05020457 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05020457
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2025-12-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.